As of 2024-12-15, the Intrinsic Value of Kalvista Pharmaceuticals Inc (KALV) is
-14.44 USD. This KALV valuation is based on the model Peter Lynch Fair Value.
With the current market price of 8.75 USD, the upside of Kalvista Pharmaceuticals Inc is
-265.15%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-14.44 USD
Intrinsic Value
KALV Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-14.44 - -14.44 |
-14.44 |
-265.15% |
| P/E |
(15.60) - (50.55) |
(34.01) |
-488.9% |
| DDM - Stable |
(21.53) - (58.64) |
(40.08) |
-558.4% |
| DDM - Multi |
(4.50) - (9.67) |
(6.16) |
-170.4% |
KALV Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
429.20 |
| Beta |
1.41 |
| Outstanding shares (mil) |
49.08 |
| Enterprise Value (mil) |
397.36 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.91% |
| Cost of Debt |
5.00% |
| WACC |
7.29% |